Venmax Drugs & Pharmaceuticals informs about statement of investor complaints

21 Jul 2017 Evaluate

Venmax Drugs & Pharmaceuticals has informed about the Statement of Investor Complaints for the Quarter ended 30th June 2017 under regulation 13 (3) of the SEBI (LODR) Regulation 2015.

The above information is a part of company’s filings submitted to BSE.

Venmax Drugs&Pharma Share Price

27.60 -1.40 (-4.83%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×